Bo Ding Selected Research

fluchloralin

1/2021

Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Ding Research Topics

Disease

22	Rheumatoid Arthritis 08/2014 - 09/2007
21	Neoplasms (Cancer) 01/2022 - 04/2010
17	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2011
12	Inflammation (Inflammations) 01/2022 - 06/2003
10	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2021 - 02/2012
8	Hearing Loss (Hearing Impairment) 01/2022 - 01/2016
8	Asthma (Bronchial Asthma) 06/2021 - 01/2017
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2017
4	Hypoglycemia (Reactive Hypoglycemia) 05/2021 - 12/2018
3	Hypoxia (Hypoxemia) 01/2022 - 07/2009
3	Gliosis 01/2022 - 09/2020
3	Presbycusis 06/2021 - 11/2017
3	Adenocarcinoma of Lung 01/2021 - 01/2020
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2016
3	Glioblastoma (Glioblastoma Multiforme) 08/2012 - 04/2010
2	Osteoporosis 01/2022 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2020
2	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 11/2017
2	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2021 - 01/2021
2	Hyperglycemia 01/2021 - 04/2006
2	Infections 01/2021 - 01/2014
2	Leiomyoma (Uterine Fibroids) 01/2021 - 07/2019
2	Virus Diseases (Viral Diseases) 11/2020 - 01/2013
2	Neuroinflammatory Diseases 10/2020 - 09/2020
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 03/2009
2	Atherosclerosis 04/2019 - 10/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2015
2	Insulin Resistance 01/2019 - 10/2006
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017 - 01/2013
2	Hypersensitivity (Allergy) 08/2012 - 04/2010
2	Body Weight (Weight, Body) 02/2011 - 04/2005
2	Cardiotoxicity 01/2011 - 11/2008
2	Reperfusion Injury 07/2009 - 05/2006
2	Myocardial Infarction 06/2008 - 04/2006
2	Heart Failure 06/2005 - 05/2005
1	Pain (Aches) 01/2022
1	Tinnitus 01/2022
1	Ototoxicity 01/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2011
8	Anti-Citrullinated Protein AntibodiesIBA 08/2014 - 09/2007
7	Biomarkers (Surrogate Marker)IBA 07/2021 - 08/2012
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
5	Insulin (Novolin)FDA Link 01/2022 - 12/2018
5	CytokinesIBA 07/2021 - 10/2003
4	Biological ProductsIBA 01/2022 - 01/2019
4	Ion Channels (Ion Channel)IBA 01/2022 - 01/2018
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 12/2018
4	Testosterone (Sustanon)FDA Link 01/2021 - 01/2019
4	Messenger RNA (mRNA)IBA 07/2019 - 04/2006
4	AntigensIBA 03/2016 - 01/2009
3	EnzymesIBA 01/2022 - 08/2011
3	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 02/2011
3	NF-kappa B (NF-kB)IBA 09/2020 - 06/2003
3	Mitogen-Activated Protein KinasesIBA 09/2020 - 01/2004
3	Long Noncoding RNAIBA 04/2020 - 01/2017
3	Muscarinic AntagonistsIBA 01/2020 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2019 - 10/2015
3	Protein Isoforms (Isoforms)IBA 01/2019 - 05/2006
3	AutoantibodiesIBA 08/2014 - 10/2008
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2013 - 04/2009
3	EpitopesIBA 01/2013 - 04/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012 - 10/2003
3	AntibodiesIBA 02/2011 - 01/2009
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 05/2021
2	oxidized low density lipoproteinIBA 01/2022 - 10/2015
2	Hormones (Hormone)IBA 01/2022 - 01/2020
2	LDL CholesterolIBA 01/2022 - 01/2016
2	Circular RNAIBA 11/2021 - 01/2021
2	SuspensionsIBA 10/2021 - 10/2019
2	Particulate MatterIBA 06/2021 - 01/2021
2	Air Pollutants (Pollutants, Air)IBA 06/2021 - 01/2021
2	Insulin Glargine (Lantus)FDA Link 01/2021 - 01/2020
2	pyridineIBA 11/2020 - 11/2020
2	tanshinoneIBA 10/2020 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2020 - 04/2019
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 04/2006
2	C-Reactive ProteinIBA 01/2019 - 11/2017
2	MicroRNAs (MicroRNA)IBA 01/2019 - 06/2018
2	ORALIT (ORS)IBA 03/2018 - 08/2012
2	GoldIBA 01/2018 - 01/2017
2	Complement System Proteins (Complement)IBA 01/2015 - 04/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 05/2014 - 01/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2013 - 04/2006
2	Peptides (Polypeptides)IBA 02/2011 - 12/2009
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2011 - 05/2005
2	cyclic citrullinated peptideIBA 06/2010 - 03/2009
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2009 - 09/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2008 - 06/2008
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	methyl 4-formylphenyl phosphateIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022

Therapy/Procedure

15	Therapeutics 01/2022 - 07/2010
4	Nebulizers and Vaporizers (Inhaler) 01/2019 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2020
2	Glycemic Control 01/2021 - 12/2018
2	Photothermal Therapy 12/2020 - 01/2020
2	Metered Dose Inhalers (Metered Dose Inhaler) 01/2019 - 01/2018
1	Myofascial Release Therapy 01/2022